Aesthetic Medical International Holdings
AIH was delisted on the 20th of May, 2024.
6 hedge funds and large institutions have $1.17M invested in Aesthetic Medical International Holdings in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 5 → 6 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.66% less ownership
Funds ownership: 2.79% → 2.12% (-0.66%)
16% less capital invested
Capital invested by funds: $1.4M → $1.17M (-$226K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$25.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$5.21K |
AIH Hedge Fund Activity: Q3 2022 in Review
6 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Aesthetic Medical International Holdings (AIH) for Q3 2022, worth a combined $1.17M — down 16% from $1.4M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new AIH positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $25.3K. The largest seller was UBS Group, cutting an estimated $5.21K.
- 6 institutional investors held Aesthetic Medical International Holdings (AIH) as of Q3 2022, up from 5 in Q2 2022.
- Funds reported $1.17M of Aesthetic Medical International Holdings stock for Q3 2022, down 16% quarter-over-quarter.
- 1 fund opened new Aesthetic Medical International Holdings positions in Q3 2022 and 0 closed out, a net change of +1 holder.
- The largest Aesthetic Medical International Holdings buyer in Q3 2022 was Citadel Advisors, an estimated $25.3K added.
- The largest Aesthetic Medical International Holdings seller in Q3 2022 was UBS Group, an estimated $5.21K sold.
Based on aggregated 13F filings for Q3 2022.